Overview
Find detailed information selected clinical trials for other forms of Leukemia, not yet mentioned, at Cincinnati Children's Hospital Medical Center.
There are two versions of some of the trials. While they contain the same basic information, one version is geared toward healthcare professionals and the other is geared toward families.
| Trials | Healthcare Professionals Version | Family-Friendly Version |
|---|
| ADVL0416: A Phase 1 Study of SAHA In Pediatric Patients with Recurrent or Refractory Solid Tumors (Including Lymphomas) and Leukemia Followed by a Phase I Study of SAHA in Combination with 13 Cis-Retinoic Acid for Patients with Selected Recurrent/Refractory Solid Tumors | Professional | Family-Friendly |
| OSU 0479: Flavopiridol in Treating Patients with Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia | Professional | Family-Friendly |
| ADVL0413: Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children with Refractory Solid Tumors or Refractory Leukemias | Professional | Family-Friendly |
| ASCT0631:Phase III Randomized Study of Filgrastim (G-CSF)-Stimulated Allogeneic Bone Marrow Transplantation Versus Conventional Bone Marrow Transplantation in Pediatric Patients With Hematologic Cancer or Other Diseases | Professional | Not Available |
